Trials / Conditions / Human Papillomavirus-Related Carcinoma

Human Papillomavirus-Related Carcinoma

18 registered clinical trials studyying Human Papillomavirus-Related Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive M NCT04142398	AIDS Malignancy Consortium	—
Not Yet Recruiting	Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Com NCT06926062	Fred Hutchinson Cancer Center	N/A
Recruiting	A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial NCT07104240	Emory University	N/A
Recruiting	Testing RG1-VLP Vaccine to Prevent HPV-related Cancers NCT05985681	National Cancer Institute (NCI)	Phase 1
Terminated	Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacie NCT05831540	Fred Hutchinson Cancer Center	N/A
Withdrawn	Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcino NCT05472220	Pamela Munster	Phase 1
Active Not Recruiting	A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Pap NCT05232851	Mayo Clinic	Phase 1 / Phase 2
Completed	Human Papillomavirus Education Programs NCT04880837	Ohio State University Comprehensive Cancer Center	N/A
Completed	HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer NCT04580446	University of Texas Southwestern Medical Center	Phase 1
Completed	HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved A NCT04474821	Mayo Clinic	Phase 4
Completed	Molecular Signatures of HPV+ ORL Cancers (OROPAP) NCT04189003	Assistance Publique - Hôpitaux de Paris	—
Active Not Recruiting	MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA V NCT03634267	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients NCT03036930	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Par NCT02568566	National Cancer Institute (NCI)	Phase 2
Completed	HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA NCT02379520	Baylor College of Medicine	Phase 1
Recruiting	Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening NCT04927650	University of California, San Francisco	—
Completed	Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients NCT02624349	The Hospital for Sick Children	Phase 4
Completed	MeFirst: A Tailored Intervention to HPV Vaccine Decision Making NCT01769560	University of Michigan	N/A